Adaptation of avian influenza viruses for replication and transmission in the human host is believed to require mutations in the hemagglutinin glycoprotein (HA) which enable binding to human α2-6 sialosides and concomitant reduction in affinity for avian α2-3 linked sialosides. Here, we show by glycan microarray analyses that the two mutations responsible for such specificity changes in 1957 H2N2 and 1968 H3N2 pandemic viruses, when inserted into recombinant HAs or intact viruses of some recent avian H5N1 isolates (clade 2.2), impart such attributes. This propensity to adapt to human receptors is primarily dependent on arginine at position 193 within the receptor-binding site, as well as loss of a vicinal glycosylation site. Widespread occurrence of these susceptible H5N1 clade 2.2 influenza strains has already occurred in Europe, the Middle East, and Africa. Thus, these avian strains should be considered high-risk, because of their significantly lower threshold for acquiring human receptor specificity and, therefore, warrant increased surveillance and further study.
Introduction
The H5N1 avian influenza virus is now firmly established on three continents and is threatening further globalization in the coming months/years. The ongoing concern is whether the avian H5N1 virus will evolve to allow efficient human-to-human transmission, which could potentially initiate a deadly pandemic. The hemagglutinins (HAs) of avian H5N1 viruses can be separated into ten distinct phylogenetic clades (0-9). 1 Due to increased diversity, clade 2 viruses were recently further sub-divided into 5 second-order clades (2.1-2.5). Table 1 ). 2, 3 The likelihood that the H5N1 virus can cause a pandemic in humans by reassortment with current human viruses, as demonstrated for the H2 and H3 pandemics in 1957 and 1968, is the subject of ongoing debate. [4] [5] [6] Direct adaptation to humans is more challenging for the virus, since it must acquire the ability to enter, and to replicate efficiently in the critical upper airway cells of the new host, involving optimization of many steps in viral replication. The virus must also be transmissible from human-to-human to spread in the population, which is a property distinct from entry and replication. Although a number of factors determine host range restriction and pathogenicity, 7 a recent study of the 1918 pandemic virus in a ferret model highlighted the receptor specificity of the influenza hemagglutinin (HA) as a critical determinant. 8 Recent in vitro investigations of certain HA mutations on the H5N1 virus receptor binding also suggest the critical role of receptor specificity in infection of the upper human airway. [9] [10] [11] [12] [13] [14] A characteristic of human influenza viruses is a pronounced preference for binding to α2-6 linked sialic acids, while avian viruses recognize receptors with α2-3 linked sialic acids. Several reports have documented mutants of H5N1 that have modest affinity for α2-6 sialic acids. [11] [12] [13] However, these reports studied only viruses from clade 1 and, although different assay methods were used, a consistent feature of these mutants is that they retained predominant avian-type specificity for α2-3 linked sialic acids. [11] [12] [13] Here, we have analyzed recent avian H5N1 viruses from different evolutionary clades that have been reported to infect humans, and assessed their propensity to acquire human receptor specificity. Our studies have focused on viruses of clades 1, 2.1 and 2.2, because these clades have been responsible for N 90% of the human infections since 2003. We have used glycan array analyses, [9] [10] [11] 15 covering a wide range of natural sialosides (Table 2 ) to compare and contrast the receptor-binding capabilities of natural and mutated avian influenza viruses, both as recombinant HAs (rHAs), 11, 16 and as corresponding viruses produced by reverse genetics.
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Results
We selected diverse representative hemagglutinins from the different clades of circulating avian H5N1 influenza viruses isolated from humans. To compare results of different virus preparations on glycan microarrays, optimization experiments revealed that it is necessary to use comparable HA titers, since high viral titers lead to signal saturation of strong binders and exaggerates the signals (and the physiological/biological relevance) for weakly binding glycans, while suboptimal titers detect only binding to high-affinity ligands (Fig. 2) . How effectively a virus binds to the representative glycans can be tested by assaying at different virus dilutions. As seen for A/Vietnam/1203/2004 (Viet04; Fig. 2) , this virus has a strong preference to bind α2-3 sialosides, but weak binding to certain α2-6 sialosides, including biantennary (40 and 41) and long-chain (49 and 50) glycans, is revealed as virus titers are increased (from 128 to 512). Dilution to an HA titer of 64 resulted in complete loss of the α2-6 signals, while binding to the α2-3 glycans is minimally affected. Each experiment, therefore, requires careful titration of the virus on the array to derive meaningful data. In our experiments, an HA titer of 128 appeared to be optimal for comparison of receptor specificity, and produced sufficient binding to evaluate receptor specificity without saturation of signals to highaffinity glycans and exaggeration of signals to glycans with lower affinity.
Representatives from a number of clades were analyzed (Fig. 3) (Fig. 3) . However, all assays with the HK213 and Viet04 viruses (both clade 1), as well as A/Indonesia/05/2005 (Indo05; clade 2.1), revealed some additional, albeit less extensive, binding to α2-6 sialosides, in particular to biantennary glycans (40 and 41 in Fig. 3) . Furthermore, the A/ Hong Kong/213/2003 (HK213) strain was of particular interest because a previous study reported an increase in human-type α2-6 specificity and identified a Ser227Asn mutation as a possible cause. 20 However, our results suggest no increase in α2-6 binding for this particular strain. Glycan microarray analyses of A/ Vietnam/1203/2004 (Viet04) and HK213 viruses revealed similar binding profiles with specific interaction of HK213 only to α2-6 biantennary structures (40 and 41) (Fig. 3) . A/Indonesia/05/2005 (Indo05) had similar binding profiles, but with enhanced binding to several monovalent α2-6 sialosides, including 6′-sialylactose (#45) and long-chain sialosides (49 and 50) (Fig. 3) . Only the clade 0 human virus A/Hong Kong/486/1997 (HK486) and the clade 2.2 Egyptian virus A/Egret/Egypt/1162/NAMRU-3/ 2006 (Egret06), isolated from an egret, failed to bind to α2-6 sialosides.
H2/H3 adaptive mutations
The previous two human influenza pandemics in 1957 and 1968 resulted from introduction of avian virus hemagglutinins H2 and H3, respectively, into the currently circulating human virus population by gene reassortment. In each case, the HAs adapted to human-type receptor specificity through two amino acid mutations in the receptor-binding pocket (Gln226Leu, Gly228Ser; LS). 21, 22 In our earlier studies of the Viet04 strain (clade 1), one of the most highly pathogenic strains in ferret and mouse models, 23, 24 we studied the effect of these mutations, as well as 190/225 mutations found to switch receptor specificity in H1N1 viruses, and only the introduction of H2/H3 mutations into the recombinant H5 HA resulted in reduced α2-3 binding, and facilitated a relatively modest interaction with α2-6 biantennary glycans. 11 To further investigate the potential for such mutations to adapt the H5 HA to human-type receptor specificity, we have evaluated the effect of these same mutations in viruses that represent more recent clades. Mutant viruses were generated by reverse genetics, as well as their corresponding rHAs using a baculovirus expression system, from clade 0 (HK486-LS), clade 1 (Viet04-LS), clade 2.1 (Indo05-LS from clade 2.1) and clade 2.2 (Egret06-LS) viruses, and all were analyzed on the glycan microarray.
For avian viruses to adapt for efficient human-tohuman transmission, it is thought that mutations in the HA are required that can decrease α2-3 binding, while simultaneously increasing α2-6 specificity. 25 For the recombinant HA experiments (Fig. 4 , righthand column), introduction of H2 and H3 serotype mutations (Gln226Leu, Gly228Ser) produced a significant reduction in α2-3 binding, when compared to their wild-type counterparts (Fig. 3) . For α2-6 binding, however, a highly significant increase was observed only for clade 2.2 Egret06-LS, where binding to a greater range of α2-6 sialosides was apparent compared to the highly restricted interaction for clade 1 and 2.1 HAs with biantennary sugars (40 and 41). For intact viruses, a similar pattern was noted, with Egret06-LS again showing the most significant increase in binding to human-type α2-6 receptors and concomitant decrease in interaction with aviantype α2-3 receptors (Fig. 4 , left-hand column). Gln226Leu/Gly228Ser mutations into the progenitor H5N1 virus (A/Hong Kong/486/1997) resulted in a binding profile similar to that of Viet04-LS with dual α2-3/α2-6 specificity (Fig. 4 , left-hand column). The predominant binding to avian-type receptors appeared to be for fucosylated α2-3 sialosides with the sialyl-Lewis X structure (NeuAcα2-3Galβ1-4 (Fucα1-3)GlcNAc-(24-28), although linear, longchain sialosides were also bound (19, 20, and 30) .
Clade-specific differences
Until recently, viruses circulating since 2003 fell into phylogenetic clades 1 and 2, with the latter further Comparison of receptor specificity of representative H5N1 viruses (column 1) and corresponding recombinant HAs (column 2) using a glycan microarray. A number of HAs from 1997 to 2005 isolated from human infections were analyzed and compared. Viruses were analyzed at a HA titer of 128/50 μl while 15 μg of recombinant HA was used for the complementary analysis. Binding to different categories of glycans on the array are highlighted as follows: red, α2-3 sulfated; green, α2-3 di-sialylated, yellow, linear α2-3 sialosides; orange, fucosylated α2-3 sialosides; blue, α2-3 internal sialosides; and pink α2-6 ligands in same order as listed for the α2-3 sialosides (see Table 2 for the name list and structures). Because additional glycans were added to the microarrays during the course of this study, glycans 1, 21, 22, 29, 31, 36, and 53 are absent from certain graphs. (Table 1) . 2, 3 Recently, the H5N1 nomenclature has been revised and ten distinct phylogenetic clades (0-9) are defined.
1 Despite this Fig. 4 . Impact of LS mutations propensities of recent H5N1 isolates to bind human-type receptors. Mutations responsible for adaptation of the 1968 H3 pandemic strain (Gln226Leu, Gly228Ser) to human-type receptor specificity were introduced into H5N1 viruses by reverse genetics (column 1) and the corresponding recombinant HAs (column 2). Mutations in the clade 1 strain, A/Vietnam/1203/2004 (row 2) and a clade 2.1 strain; A/Indonesia/05/2005 (row 3) both show reduced avian α2-3 specificity, and acquire weak binding to α2-6 glycans, in particular to α2-6 biantennary glycans (40, 41) . Most striking is the effect of the same mutations on the clade 2.2 avian virus, A/Egret/Egypt/1162/NAMRU-3/ 2006 (row 4), which shows substantially reduced avian α2-3 specificity, and significant binding to a wide spectrum of α2-6 glycans. Virus and recombinant HAs were analyzed as in Fig. 3. revision, all avian H5N1 viruses that have infected humans since 2003, except for one case from Beijing, China in 2003 (clade 7), can still be grouped into only two phylogenetic clades (1 and 2; see Fig. 1 and Table  1 ). Our analysis of the receptor binding domain (RBD) structure, with respect to known sequences of clade 1 and 2 H5N1 viruses identified residues at positions 158 and 193 (in H3 numbering) that can be considered clade-specific differences (Fig. 1) . (Fig. 1) . Structurally, this residue could affect receptor specificity, as it resides on the α-helix that sits atop the RBD (Fig. 5a) . Another important feature in the evolution of H5N1 viruses has been the acquisition of a glycosylation site at position 158, atop and to one side of the RBD (Fig. 5b) that importantly has been subsequently lost in clade 2.2. Although glycosylation is a critical feature for immune escape by masking antigenic sites, 26, 27 this effect is not considered a major selective force in unvaccinated birds. 28 In addition, although often overlooked, glycosylation has a role in RBD function and specificity (Fig. 5b) . Binding data using the glycan microarray, as well as cell-based assays using intact viruses, have shown that N-linked glycans close to the RBD in other HA subtypes can affect receptor binding through steric hindrance or other mechanisms. 10, 29, 30 Whereas the majority of H5N1 viruses have acquired a glycosylation site at 158, recent clade 2.2 H5N1 isolates that have spread into Europe, Africa and the Middle East, notably lack this carbohydrate-attachment site (Fig. 1) .
To determine the role of these two clade-dependent differences on the propensity of the clade 2.2 (Egret06) virus to acquire a predominant human-type α2-6 specificity via introduction of the Gln226Leu, Gly228-Ser (LS) mutations, we constructed additional mutants using the Viet04-LS and Indo05 HA frameworks. Introduction of the clade 2.1/2.2-specific Lys193Arg mutation onto the clade 1 Viet04-LS HA framework (Viet04-RLS), resulted in a significant increase in binding to α2-6 glycans, but only a marginal reduction for avian α2-3 sialosides for the recombinant HA (cf. Fig. 4 , row 2 and Fig. 6, row 1) . The improved α2-6 binding of recombinant Viet04-RLS HA was superior to that of recombinant Indo05-LS HA (Fig. 4, row 3) , which already has a natural Arg at position 193, suggesting that other features might contribute to receptor specificity. Removal of the glycosylation site at Asn158 (Asn-Ser-Thr to Asn-SerAla) on the Viet04 framework (Viet04-ALS) resulted Structural model of the Viet04 HA trimer illustrating the direction that α2-6 sialosides exit the HA RBD and the role that a vicinal glycosylation site may have in steric hindrance. One monomer of the trimer was modeled with the lactoseries pentasaccharide, LSTc from the swine H9 HA co-crystal structure (PDB1JSI) 31 in the RBD. A biantennary glycan, commonly found on influenza viruses, 40, 41 was manually appended to the glycosylation site at Asn158 to illustrate the size of such a structure and how it may influence access to the RBD. in very weak α2-3 and α2-6 binding (Fig. 6, row 2) , whereas this same mutation on the Indo05 framework (Indo05-ALS) greatly reduced α2-3 binding, and substantially increased α2-6 specificity for both recombinant HAs (Fig. 6, row 3) . Effects of these mutations on their corresponding virus (Fig. 6 ) are less obvious and may be due to avidity effects. Comparison of the Indo05 HA to Viet04 HA reveals a further six residues that differ in and around the RBD (Fig. 5a) and, of these, Leu133Ser is within the binding site and may further affect specificity for α2-6 residues. Interestingly, the RBD of a swine H9 interacts with the α2-6 receptor analog, LS-Tetrasaccharide c (LSTc), through hydrogen bonds between the glucose of the receptor analog and residues 131 and 133 of H5 HA. 31 
Discussion
It is clear then from our results and others ( Fig. 3 and see Ref. 12 ) that recent avian viruses (2003) (2004) (2005) isolated from humans exhibit weak affinity for α2-6 sialosides, particularly for α2-6 biantennary glycans. In the experiments reported here, the corresponding rHAs in fact show little α2-6 binding (Fig. 3, right  column) , and illustrates that increased valency of the HAs on the intact virus surface amplifies the signal for weak interactions with carbohydrate ligands on the array that are likely non-physiological (Fig. 1) . Fortunately, the natural mutations that have accumulated in the evolution of these H5N1 viruses since 1996/7 have not enabled human-to-human transmission, although a number of individuals have been infected, many of whom have died. Whether pre-existing mutations in the wild-type viruses have facilitated this incidence of human infection or, in fact, were selected for during replication in the human host is not known.
Certain terrestrial birds, such as quails and chickens, have recently been shown to present both human and avian types of receptors in the trachea and intestine. [32] [33] [34] Thus, prolonged circulation of these viruses in terrestrial birds, such as domestic chickens, may provide a possible route for the virus to develop the receptor specificity needed for efficient human infection. 35 Clade 2.1 viruses have circulated extensively in Indonesian poultry since 2003, and that country has reported the most cases of human infection with H5N1 so far. Interestingly, in support of this hypothesis, our analysis of a wildtype, avian isolate, clade 2.2 Egret06 virus revealed only avian α2-3 receptor specificity with no detectable binding to human-type receptors (Fig. 3) .
In light of the global public health concern with H5N1, it is critical to understand fully, and to anticipate, what mutations might enable H5N1 viruses to evolve into a pandemic influenza strain, either directly or via reassortment with an existing human virus. Our previous results 11 indicated that the two mutations known to convert H3 serotypes from avian to human receptor specificity could constitute a possible route for adaptation of clade 1 H5N1 viruses to human receptors. However, although some highly restricted binding to biantennary α2-6 sugars was acquired, substantial residual binding activity for a wide range of avian-type α2-3 sugars still predominated.
In this study, we focused on the evolution of current H5N1 viral strains, some of which were not available at the time of our previous study. We have now identified two natural mutations at positions 193 and 158 in the HA envelope glycoprotein that substantially enhance binding of recombinant H5N1 HAs to human-type receptors when combined with the receptor-switching substitutions of pandemic H3 viruses. Interestingly, acquisition of Arg193 and loss of a glycosylation site at Asn158 have both arisen in clade 2.2 viruses that have recently spread into Europe, the Middle East and Africa. Arg193 is a specific feature of clades 2.1 and 2.2, and increases affinity for α2-6 sialosides, in combination with the receptor-switching H3 mutations, possibly through acquisition of multiple hydrogen bonds to the third GlcNAc sugar of these sialylated glycans (Fig. 7) . Significantly, the H3 receptor-switching mutations (Gln226Leu/Gly228Ser) have a much more significant effect on these recent viruses. Several human influenza viruses have been demonstrated recently to exhibit preference for long-chain α2-6 sialosides, 10,14,36 a specificity that has been proposed by Chandrasekharan et al., to be characteristic of human viruses required for efficient replication and transmission in humans.
14 In this study, it is notable, however, that the clade 2 viruses with the Gln226Leu/Gly228Ser mutations exhibit broad specificity for sialosides with the Neu5Acα2-6Gal sequence, that include, but are not limited to, longchain sialosides (e.g. glycans 49 and 50).
Our results highlight the complexity of assessing the likelihood of adaptation to human receptor specificity from analyses of only one influenza strain. We have shown that the effect of single or multiple mutations on the framework of one strain may not produce an equivalent result on another from a different clade. These findings underscore the importance of continuing to assess how the virus is evolving in real time in susceptible hosts, and the need to constantly evaluate new virus isolates with respect to mutations that could substantially alter or influence receptor specificity or virulence. Thus, immediate access to, and evaluation of, current and emerging strains is of critical importance. Our goal has been to ascertain which mutations could constitute a viable route for H5N1 viruses to adapt to human receptors. The two H3 mutations that are so effective in our in vitro experiments on certain natural H5N1 strains have not occurred in nature and there may be some, as yet, unidentified reasons why avian H5N1 viruses cannot readily adapt in vivo via this route. One possibility is that such viruses are not viable in birds, precluding transmission to a new mammalian host that would allow such mutations to be maintained and enriched. Hence, previous suggestions of intermediate hosts, [32] [33] [34] rather than direct avian-to-human adaptation, may be the route that this virus will take should it adapt successfully. Secondly, Lys193, which predominates in pre-2003 strains, and/or the glycosylation site at 158 (that emerged in almost all Asian sequences [2002] [2003] , might have influenced the course of evolution of the RBD so that such human adaptation has so far been suppressed.
Thus, for adaptation to a human host, the probability that a clade 1 avian H5N1 virus would acquire four simultaneous mutations at positions 158, 193, 226 and 228 is extremely low. However, the acquisition of Arg at position 193, and the recent emergence of viruses that lack a glycosylation site at position 158, are natural features of the clade 2.2 family that is circulating in Europe, the Middle East and Africa. Thus, the number of mutations required to change receptor specificity is now reduced to only two, as seen from our studies with the clade 2.2 Egypt06 virus and rHA (Figs. 3, row 5 and 4, row 4). Although these features/mutations identified here enable the HA from recent isolates to exhibit increased preference for α2-6 glycans, it remains to be seen whether such changes in receptor specificity will allow H5N1 to establish efficient replication and facilitate/sustain human-to-human transmission, since the other genes in the virus are still avian in origin and their role in human adaptation is largely unknown. These current studies highlight the functional, but variable, interdependence of multiple structural elements within and vicinal to the RBD that can influence receptor specificity. Such an intimate understanding of this host-pathogen interaction that assesses the role played by each residue in the RBD in determining receptor specificity is essential for designing intervention strategies and for assessing the risk of the emergence of future pandemics.
Materials and Methods
Cloning recombinant HAs
On the basis of H3 numbering, 37 cDNAs encoding residues 11-329 (HA1) and 11 In a similar fashion to the construct used for expression of the 1918 influenza virus HA for structural studies, 16 all constructs incorporated a Cterminal thrombin cleavage site, a foldon sequence, 38 and a His 6 tag at the extreme C-terminus of the construct to enable protein purification. Once the sequence was verified, the plasmids were used as templates for derivation of mutants. Primers containing point mutations around the receptor-binding site were designed using the online QuikChange® Primer Design Program † synthesized by Retrogen, Inc. (San Diego, CA) and used with QuickChange® II XL or QuikChange® Multi Site-directed Mutagenesis kits (Stratagene) to generate mutant HAs. Transfection and virus amplification were carried out as described. 10, 11, 16 Expression and purification Expression from Trichoplusia ni (Hi5) cells (Invitrogen, Carlsbad, CA) has been described. 11 For a typical preparation, protein was prepared from two ten-stack CellSTACK™ culture chambers (Corning Inc.) and soluble HA was recovered from the culture supernatant and purified by metal affinity chromatography and ionexchange chromatography (IEX). Samples were centrifuged to remove insect ferritin, and transferred to a clean tube. A typical yield of pure protein was approximately 2-5 mg per preparation. Samples (100-150 μg of HA protein), diluted with 10 mM Tris-HCl, 50 mM NaCl, pH 8.0 to 1 mg/mL, were set aside for glycan microarray analysis.
Virus generation
Reassortant viruses were generated from plasmids by a reverse genetics approach. [17] [18] [19] Viral HA and neuraminidase cDNAs were cloned into a pPolI plasmid vector under control of the human polymerase I promoter and the mouse RNA polymerase I terminator. All viruses generated by reverse genetics carried the HA and NA of the avian H5N1 viruses and the internal genes (PB1, PB2, PA, NP, M and NS) of A/Puerto Rico/8/34 (PR8). To generate viruses with amino acid changes in the HA, mutations were introduced into pPolI-HA using an overlap extension PCR approach, 39 and resulting plasmids were sequenced-verified. Viruses derived by plasmid transfection of HK293 cells were propagated in MDCK or eggs. Viruses recovered by reverse genetics replicated as efficiently as the parental stocks in eggs or MDCK cells (HA titers of mutant viruses were ≤2-fold greater than th corresponding wild-type parental viruses). The HA1 of resulting virus stocks were sequenced to detect the emergence of possible revertants during amplification. Sequence analysis of the Viet04-LS virus stock revealed 10-30% RNA quasi-species at several loci, whereas the other viruses analyzed during this study had quasi-species levels below the 10% detection threshold.
Glycan array fabrication and glycan array analyses
Microarray printing and recombinant HA analysis have been described. 10, 11, 15 Imprinted slides used were obtained from either the Consortium for Functional Glycomics (CFG) (glycan microarray version 2.1 ‡), or from the CDC from slides produced specifically for influenza research for the CDC using the CFG glycan library (CDC version 1 slides; see Table 2 for glycans used for analyses in these experiments). Briefly, for analysis using recombinant HA, HA-antibody complexes were prepared by mixing 15 μg of recombinant HA, mouse antipenta-His-Alexa Fluor488 (Qiagen, Valencia, CA) and anti-mouse-IgG-Alexa Fluor488 (Invitrogen, Carlsbad, CA) in a molar ratio of 4:2:1, respectively. These prepared mixtures of complexes were incubated for 15 min on ice, diluted to 1 mL with PBS-BSA (phosphate-buffered saline containing 3% (w/v) bovine serum albumin) and incubated on the microarray slide in a humidified chamber for 1 h. Slides were subsequently washed by successive rinses with PBS-T (PBS with 0.05% Tween-20), PBS, and deionized water, then immediately subjected to imaging as described. 15 Virus were analyzed on the microarray as described, 15 but with the following modification. Virus stocks were inactivated by treatment with β-propiolactone (BPL; 0.05%) for three days at 4°C. Titers were determined using 0.5% (w/v) turkey red blood cells. Since these cells contain both α2-3 and α2-6 sialoglycans, virus quantification errors due to receptor specificity differences among the viruses should be reduced. Virus preparations were diluted to 1 mL witrh PBS-BSA at hemagglutination (HA) titers N 32/50 μl. Virus suspensions were applied to slides and the slides were incubated in a closed container and subjected to gentle agitation for 1 h. Unbound virus was washed off with brief sequential washes in PBS-T and PBS. Slides were then immediately incubated with an anti-H5N1 antibody (30 min); a biotinylated anti-sheep-IgG antibody (30 min) and a streptavidin-Alexa Fluor 488 conjugate (30 min) with brief PBS-T/PBS washes after each incubation. After the final PBS-T/PBS washes, slides were washed briefly in de-ionized water and dried by a gentle steam of air or nitrogen gas and immediately subjected to imaging, as described. 15 For maximal information, different virus dilutions were analyzed using an HA titer range from 1024 to 32. (Results refer to the HA units/50 μl deduced from a standard hemagglutination inhibition assay). For the majority of samples, an HA titer of 128 units appeared to be a good approximation for maximal information gain. Typically, experiments were conducted in groups of 20 slides, which were affixed to a custom-designed 40-slide frame. Accordingly, all slides received simultaneous treatments and wash steps.
